Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950144-03-006985
Filing Date
2003-05-15
Accepted
2003-05-15 16:42:15
Documents
9
Period of Report
2003-03-31

Document Format Files

Seq Description Document Type Size
1 ADVANCE VIRAL RESEARCH CORP. FORM 10-Q g82682e10vq.txt 10-Q 206725
3 SECURITIES PURCHASE AGREEMENT g82682exv10w1.txt EX-10.1 73364
4 5% CONVERTIBLE DEBENTURE g82682exv10w2.txt EX-10.2 17545
5 WARRANT DATED 4/28/03 g82682exv10w3.txt EX-10.3 43073
6 REGISTRATION RIGHTS AGREEMENT g82682exv10w4.txt EX-10.4 45737
7 EQUITY LINE OF CREDIT AGREEMENT g82682exv10w5.txt EX-10.5 82209
8 REGISTRATION RIGHTS AGREEMENT g82682exv10w6.txt EX-10.6 44762
9 CEO CERTIFICATION g82682exv99w1.txt EX-99.1 1312
10 CFO CERTIFICATION g82682exv99w2.txt EX-99.2 1322
  Complete submission text file 0000950144-03-006985.txt   518642
Mailing Address 200 CORPORATE BOULEVARD SOUTH . YONKERS NY 10107
Business Address 200 CORPORATE BOULEVARD SOUTH . YONKERS NY 10107 9143767383
ADVANCED VIRAL RESEARCH CORP (Filer) CIK: 0000786623 (see all company filings)

EIN.: 592646820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-02262-A | Film No.: 03705533
SIC: 2834 Pharmaceutical Preparations